|
Match
|
Document |
Document Title |
|
|
7605178 |
Therapeutic compounds
Disclosed herein are compounds of the formula
therapeutic methods, compositions, and medicaments related thereto are also disclosed.
|
|
|
7547688 |
Methods for treatment of nocturia
A method for the treatment of nocturia which consists of administering to a mammal in need of such treatment a therapeutically effective amount of a nonsteroidal anti-inflammatory drug consisting...
|
|
|
7524885 |
Compounds that stimulate glucose utilization and methods of use
The invention provides novel compounds of the Formula (I) that stimulate rates of glucose oxidation in myocardial cells:
wherein W, Cyc, p, Y, X, Z, R, R 1 , R 2 , R 3 , R 4 , I, m and n...
|
|
|
7498359 |
Composition and method for preventing recurrence of stroke
By using a composition for preventing onset and/or recurrence of stroke which contains ethyl icosapentate as its effective component, onset and/or recurrence of stroke is prevented, or in...
|
|
|
7488753 |
Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof
This invention provides composition comprising a triterpenoidal saponin, comprising two side groups attached to carbon 21, and 22 of triterpenoidal saponin backbone. This invention provides a...
|
|
|
7485743 |
Oligomeric ketone compounds
A novel keto8enic compound is provided having general: Formula R(OCH(CH 3 )CH 2 C(O)) n —O-A wherein n is an integer of 3 to 10, A is the residue of a 3-keto alkan-1-ol and R is selected from the...
|
|
|
7485320 |
Liposome for incorporating large amounts of hydrophobic substances
A liposome formulation for stably incorporating high content of hydrophobic substance is disclosed. The liposome includes two phospholipids with different phase transition temperatures such as...
|
|
|
7473704 |
Cyclohexyl prostaglandin analogs as EP4-receptor agonists
The invention relates to the use of novel cyclohexyl analogues of E-type prostaglandins as EP 4 agonists, in general, and, in particular as ocular hypotensives. The cyclohexyl analogues used in...
|
|
|
7452556 |
Compositions for the treatment of pilosebaceous gland inflammations comprising aluminum fluoride
The present invention relates to compositions for the treatment of pilosebaceous gland inflammations, especially of the hair follicle and its appendages, in particular of Acne Vulgaris and...
|
|
|
7449315 |
Bifunctional energy-reversible acyl-compositions
Energy-reversible acyl conjugates, intermediates, and related compositions are disclosed. In preferred aspects, examples of such compositions include:
|
|
|
7442718 |
Inhibitors of aspartyl protease
The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors...
|
|
|
7384978 |
Compounds and methods for delivery of prostacyclin analogs
This invention pertains generally to prostacyclin analogs and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis,...
|
|
|
7365097 |
Use of at least one (dihydro)jasmonic acid derivative as a desquamating agent
Disclosed herein is the cosmetic use, as a desquamating agent, of at least one (dihydro)jasmonic acid derivative of a given formula. Further disclosed herein is a cosmetic method for smoothing the...
|
|
|
7304092 |
Compounds and methods for treating tumors, cancer and hyperproliferative diseases
The present invention relates to novel compounds, pharmaceutical compositions and methods for treating tumors, cancer and hyperproliferative diseases including psoriasis, genital warts and...
|
|
|
7285572 |
CaSR antagonist
The present invention provides a compound having a calcium-sensitive receptor antagonistic action, a pharmaceutical composition containing the compound, particularly a calcium receptor antagonist...
|
|
|
7265143 |
C-4 substituted retinoids
C-4 substituted retinoic acid analogs, synthesis methods of C-4 substituted retinoic acid analogs and methods of using C-4 substituted retinoic acid analogs to treat various cancers and...
|
|
|
7265130 |
NPY Y5 antagonist
The present invention provides a pharmaceutical composition for use as an NPY Y5 receptor antagonist comprising a compound of the formula (I):
wherein R 1 is lower alkyl, cycloalkyl or the...
|
|
|
7214710 |
Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
The present invention relates to the field of prodrugs of chemotherapeutic agents and method of use thereof.
|
|
|
7189760 |
Physiological cooling compositions containing highly purified ethyl ester of N-[[5-methyl-2-(1-methylethyl) cyclohexyl] carbonyl]glycine
The present invention provides, in one aspect, a substantially pure ethyl ester of N-[[5-methyl-2-(1-methylethyl)cyclohexyl]carbonyl]glycine. In another aspect, disclosed is a method for producing...
|
|
|
7173062 |
Method for the improvement of skin wrinkles using retinyl retinoate
The present invention relates to a method for the improvement of skin wrinkles using retinal retaliate.
|
|
|
7169811 |
Composition based on ethyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhea and acne
The present invention relates to a composition for topical use for treating and improving the aesthetic conditions of the skin, which comprises, as an active ingredient, a mixture of ethyllinoleate...
|
|
|
7128926 |
Ester compound and use thereof
It is an object of the present invention to provide a novel ester compound and the use thereof as a sex attractant. The present invention provides a compound represented by formula (I) described...
|
|
|
7115581 |
Chemically-defined non-polymeric valency platform molecules and conjugates thereof
Chemically-defined, non-polymeric valency platform molecules and conjugates comprising chemically-defined valency platform molecules and biological or chemical molecules including polynucleotide...
|
|
|
7091239 |
DNA polymerase inhibitors, mikanolide and dihydromikanolide
A method of treating proliferative diseases in warm-blooded animals comprising administering to warm-blooded animals in need thereof an amount of at least one compound selected from the group...
|
|
|
7084173 |
Compounds that stimulate glucose utilization and methods of use
The invention provides novel compounds of the Formula (I) that stimulate rates of glucose oxidation in myocardial cells. The invention also relates to pharmaceutical compositions comprising...
|
|
|
7056889 |
Compounds that bind P2Y2 or P2Y1 receptors
The invention provides peptides and compounds that can bind to P2Y 2 receptors that are useful for modulating the secretion of mucus within mucosal surfaces.
|
|
|
7056862 |
Herbicide potentiators
The invention provides an agricultural chemical enhancer and an agricultural chemical composition which are safely used for crops without any phytotoxicity, have a potency enhancing action on...
|
|
|
7053120 |
Use of carboxy compounds such as 2(4-acetoxyphenyl)2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
The present invention relates to the use of specific carboxy compounds, more specifically to the use of 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride, in the treatment of inflammatory...
|
|
|
7015243 |
Cyclohexyl prostaglandin analogs as EP4-receptor agonists
The invention relates to the use of novel cyclohexyl analogues of E-type prostaglandins as EP 4 agonists, in general, and, in particular as ocular hypotensives. The cyclohexyl analogues used in...
|
|
|
6984389 |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
The present invention relates to methods of improving a treatment outcome comprising administering a heat shock protein (HSP) preparation or an α-2-macroglobulin (α2M) preparation with a...
|
|
|
6974834 |
Process for preparing enantiomerically enriched (1S,4R) 1-acetoxy-4-hydroxycyclopent-2-ene
This invention relates to a process for the synthesis of enantiomerically enriched (1S,4R) 1-acetoxy-4-hydroxycyclopent-2-ene of Formula I, a compound useful as an intermediate in the synthesis of...
|
|
|
6958146 |
Compounds to affect insect behavior and to enhance insecticides
Various exemplary compounds, compositions and methods are disclosed. An exemplary composition includes an insecticide comprising a formula weight greater than approximately 220 and a compound...
|
|
|
RE38813 |
Retinoid compositions containing a water soluble antioxidant and a chelator
Skin care compositions comprising a water-in-oil emulsion base containing retinoids and possessing good physical and chemical stability.
|
|
|
6936636 |
5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity
Compounds of the formula:
where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side...
|
|
|
6924311 |
Methods for affecting various diseases utilizing LXR compounds
The present invention relates to methods for elevating high density lipoprotein (HDL) plasma levels, decreasing the absorption of dietary cholesterol in the intestine, decreasing the plasma level...
|
|
|
6903052 |
Nematicidal compositions and methods
The invention concerns the use of certain compounds related to fatty acids to control nematodes that infest plants or the situs of plants. Nematodes that parasitize animals can also be controlled...
|
|
|
6887899 |
Method for controlling house dust mites with a composition comprising phenylethyl propionate
Pesticidal compositions for the control of dust mites containing one or more plant essential oils. In addition, the present invention is directed to a method for controlling dust mites by applying...
|
|
|
6884821 |
Carboxylic acid derivatives and drugs containing the same
Novel carboxylic acid derivatives of general formula (I), salts of the same, esters thereof, or hydrates of them, which are useful as insulin resistance improvers; and drugs containing the...
|
|
|
6881756 |
Method for treating skin disorders
The present invention relates to a method for reducing inflammation in the skin and/or treating inflammatory skin disorders, pain, or pruritis by topically applying a composition comprising totarol...
|
|
|
6864278 |
Antifungal agents of sordarin derivatives
Sordarin derivatives prepared from C-11-hydroxysordarin are antifungal agents useful in the treatment and/or prevention of human and animal fungal infections, as well as in the control of...
|
|
|
6858649 |
Selective potentiation of serotonin receptor subtypes
The selective potentiation and/or inhibition of the 5-HT 2A and/or 5-HT 1A response to serotonin (5-HT) is achieved using analogs of oleamide. Selective potentiation and/or inhibition of the 5-HT...
|
|
|
6835719 |
Pesticidal composition
An environmentally safe pesticidal liquid suspension composition including a mixture of sulfur combined with pyrethrins and/or pyrethroids is provided. The pesticidal composition is effective to...
|
|
|
6833388 |
Adamantane derivative
There is provided a trisadamantane based compound which is useful not only as a photoresist additive but also as pharmaceuticals, an agrochemical intermediate, a resin additive (heat resistance...
|
|
|
6831101 |
Tricyclic rantes receptor ligands
In various aspects, the invention provides compounds that bind to one or more RANTES receptors for the treatment of chemokine mediated disease states, such as compounds of formula (I):
|
|
|
6828337 |
Selective retinoid agonists
This invention relates to new RAR selective retinoid agonists of formula I wherein the symbols are as defined in the specification to their pharmaceutically acceptable salts, individual isomers...
|
|
|
6818638 |
Melvinolin derivatives
Mevinolin derivatives wherein the lactone ring is modified have interesting pharmaceutical properties, particularly in preventing or treating disorders or diseases mediated by LFA-1/ICAM-1...
|
|
|
6815465 |
Heterocyclic compounds inhibiting angiogenesis
The invention relates to compounds of general formula (I) wherein R stands for a group of general formula —COOR 1 , —CONR 2 R 3 , —CONR 4 CONR 4 R 5 or —CH 2 OR 6 , wherein R 1 stands for...
|
|
|
6806281 |
Analogs of cocaine
The invention provides a compound of formula (I): wherein R 1 , R 2 , R 3 , and Y have any of the meanings defined in the specification; as well a pharmaceutical composition comprising a...
|
|
|
6806261 |
Methods for treating certain diseases using naaladase inhibitors
The present invention relates to methods for regulating the release of TGF-β from living cells in vitro or in vivo, comprising bringing the cells into contact with an effective amount of a...
|
|
|
6803057 |
Hydrogen peroxide disinfectant with increased activity
An acidic aqueous hydrogen peroxide solution is provided with improved disinfectant activity. Concentrated solutions preferably contain up to about 8 wt./wt. % H2O2 and as-used concentrations...
|